April 10, 2026
UNC Researchers Demonstrate Drug’s Effectiveness in Drawing Out Dormant HIV from Immune Cells
The study shows that drug citarinostat can awaken hidden HIV, advancing efforts towards a potential cure for the complex virus.
Category: HIV/AIDS
September 24, 2025
Mungo Awarded $2.5M for Research Project to Improve HPV Treatment Outcomes for Women Living with HIV
Chemtai Mungo, MD, MPH, FACOG, has been awarded $2.5M over five years by the National Institutes of Health for her research focused on improving human papillomavirus treatment outcomes in women living with HIV in Africa.
June 26, 2025
Groundbreaking Twice-Yearly HIV Prevention Injection Approved by FDA
UNC School of Medicine’s Joe Eron, MD, an expert on HIV transmission and drug development, led a clinical trial on the new medication, which has the potential to resolve the HIV epidemic around the world.
March 6, 2025
Meet The Researcher Who Is Revolutionizing Women’s Health
Rahima Benhabbour, PhD, a tenured associate professor of biomedical engineering, is developing the first 3D-printed intravaginal ring, revolutionizing how women receive treatments for infertility, HIV, menopause, and more.
May 15, 2024
Jiang Receives $4.46-million NIMH Grant
Guochun Jiang, PhD, assistant professor of biochemistry and biophysics and member of the UNC HIV Cure Center, received an R01 grant from the National Institute of Mental Health for his project “Defining the HIV reservoir and latency mechanism in human brain myeloid cells” which is funded for five years and $4.6 million.
February 13, 2024
New Trial Highlights Incremental Progress Towards a Cure for HIV-1
Cynthia L. Gay, MD, MPH, associate professor of infectious diseases, and David Margolis, MD, the Sarah Kenan Distinguished Professor of Medicine, Microbiology & Immunology, and Epidemiology in the UNC School of Medicine, published results of a clinical trial showing that vorinostat and immunotherapy may modestly shrink the latent HIV reservoir.
December 15, 2023
UNC-Chapel Hill Named National HIV Residency Pathway Consortium Site
UNC-Chapel Hill was recently named a National HIV Residency Pathway Consortium Site and awarded a year-long, $68,000 grant to support its efforts in training family medicine and internal medicine residents in caring for people with HIV. UNC’s site Investigators, Rick Moore, MD, and Louise Rambo King, MD, have a storied history of caring for patients with HIV.
November 14, 2023
Lyerly Talks Pregnant and Lactating in HIV Research in Px Pulse Podcast
Anne Drapkin Lyerly, MD, professor of Social Medicine and research professor in Obstetrics and Gynecology at the UNC School of Medicine, talks HIV research in pregnant and lactating women in Px Pulse podcast.
August 10, 2023
Gut Microbiome Can Increase Risk, Severity of HIV, EBV Disease
UNC School of Medicine researchers Angela Wahl, PhD, Balfour Sartor MD, J. Victor Garcia, PhD, and colleagues created a germ-free mouse model to evaluate the role of the microbiome in the infection, replication, and pathogenesis of HIV and Epstein-Barr virus, the virus that can cause mononucleosis and other serious diseases.
February 9, 2023
CDC-UNC Collaboration Yields Potential Long-term HIV Protection
Rahima Benhabbour, PhD, MSc, associate professor of Biomedical Engineering, led a successful effort to create an injectable implant that can release effective HIV PrEP medications into the body for six months in non-human primates.
January 30, 2023
Scientists Document Two Separate Reservoirs of Latent HIV in Patients
This research, led by UNC School of Medicine scientists Laura Kincer, Sarah Joseph, PhD, and Ron Swanstrom, PhD, with international collaborators, shows that in addition to HIV’s ability to lay dormant in the blood/lymphoid system, the virus may also lay dormant in the central nervous system, delineating another challenge in creating a cure.
January 30, 2023
UNC Receives NIH Grant to Improve HIV-Related Cancer Care Abroad
Carla Chibwesha, MD, MSc, an associate professor of obstetrics and gynecology in the University of North Carolina’s Division of Global Women’s Health and the UNC Lineberger Comprehensive Cancer Center, will work with researchers at Weill Cornell Medicine and Moffitt Cancer Center develop trials to be conducted at clinical sites in Kenya, Uganda and Botswana.